Planned sale of 3,822 common shares disclosed

A shareholder in OLMA has filed a Form 144 notice covering a potential sale of 3,822 shares of common stock through Fidelity Brokerage Services on the NASDAQ market, with an aggregate market value of $107,069.20 as reported.

Rhea-AI Filing Summary

A shareholder in OLMA has filed a Form 144 notice covering a potential sale of 3,822 shares of common stock through Fidelity Brokerage Services on the NASDAQ market, with an aggregate market value of $107,069.20 as reported. The notice states that 68,659,923 shares of this class are outstanding. The shares to be sold were acquired through employee-related transactions, including ESPP purchases on 05/14/2021 and 11/15/2021 totaling 2,517 shares for cash, and 1,305 shares received via restricted stock vesting on 12/09/2024 as compensation.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the OLMA Form 144 filing disclose?

It discloses that a shareholder has filed a Form 144 for a potential sale of 3,822 OLMA common shares, with an aggregate market value of $107,069.20, to be sold through Fidelity on the NASDAQ.

How many OLMA shares are covered by this planned sale?

The Form 144 covers a proposed sale of 3,822 shares of OLMA common stock.

How were the OLMA shares in the Form 144 acquired?

The shares were acquired via ESPP purchases on 05/14/2021 (2,079 shares) and 11/15/2021 (438 shares) for cash, and 1,305 shares from restricted stock vesting on 12/09/2024 as compensation.

What is the reported market value of the OLMA shares to be sold?

The aggregate market value of the 3,822 OLMA shares listed for potential sale is $107,069.20.

How many OLMA shares are outstanding according to the notice?

The notice reports that 68,659,923 shares of OLMA common stock are outstanding.

When is the approximate sale date for the OLMA shares in this Form 144?

The approximate date of sale stated in the Form 144 is 01/13/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/13/2026 - 04:49 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001579397
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Olema Pharmaceuticals, Inc.
SEC File Number	001-39712
Address of Issuer	780 BRANNAN STREET SAN FRANCISCO CALIFORNIA 94103
Phone	(415) 651-3316
Name of Person for Whose Account the Securities are To Be Sold	Kovacs Shane William Charles
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3822	107069.20	68659923	01/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/14/2021	ESPP Purchase	Issuer			2079	05/14/2021	Cash
Common	11/15/2021	ESPP Purchase	Issuer			438	11/15/2021	Cash
Common	12/09/2024	Restricted Stock Vesting	Issuer			1305	12/09/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	01/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gary Redman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Shane W. Kovacs
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)